Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 7439698, 8 pages
https://doi.org/10.1155/2017/7439698
Research Article

Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer

1Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
2Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
3School of Laboratory Medicine, Hubei University of Traditional Chinese Medicine, Wuhan, Hubei, China

Correspondence should be addressed to Jiancheng Tu; nc.ude.uhw@utgnehcnaij and Yong Ning; moc.361@821gnoygnin

Received 4 June 2017; Revised 12 July 2017; Accepted 27 July 2017; Published 19 November 2017

Academic Editor: Olav Lapaire

Copyright © 2017 Nandi Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Yang, B. Z. Chen, D. F. Li et al., “Reduced NM23 protein level correlates with worse clinicopathologic features in colorectal cancers: a meta-analysis of pooled data,” Medicine (Baltimore), vol. 95, article e2589, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Ettinger, D. E. Wood, W. Akerley et al., “Non-small cell lung cancer, version 6.2015,” Journal of the National Comprehensive Cancer Network, vol. 13, no. 5, pp. 515–524, 2015. View at Google Scholar
  3. Y. Wu, H. Liu, X. Shi, Y. Yao, W. Yang, and Y. Song, “The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma,” Oncotarget, vol. 6, no. 11, pp. 9160–9172, 2015. View at Publisher · View at Google Scholar
  4. T. Kishikawa, M. Otsuka, M. Ohno, T. Yoshikawa, A. Takata, and K. Koike, “Circulating RNAs as new biomarkers for detecting pancreatic cancer,” World Journal of Gastroenterology, vol. 21, no. 28, pp. 8527–8540, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Imaoka, Y. Toiyama, H. Fujikawa et al., “Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer,” Annals of Oncology, vol. 27, no. 10, pp. 1879–1886, 2016. View at Publisher · View at Google Scholar
  6. X. Gu, J. Q. Xue, S. J. Han, S. Y. Qian, and W. H. Zhang, “Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer,” Cancer Biomarkers, vol. 16, no. 3, pp. 395–403, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Qiu, J. Zhang, W. Shi et al., “Circulating microRNA-26a in plasma and its potential diagnostic value in gastric cancer,” PLoS One, vol. 11, no. 3, article e0151345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Reis and S. Verjovski-Almeida, “Perspectives of long non-coding RNAs in cancer diagnostics,” Frontiers in Genetics, vol. 3, p. 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Zhao, J. X. Sun, Y. X. Song et al., “A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion,” Journal of Cancer Research and Clinical Oncology, vol. 142, no. 3, pp. 601–609, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Shao, M. Ye, X. Jiang et al., “Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer,” Cancer, vol. 120, no. 2, pp. 3320–3328, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Yang, X. Lu, and L. Yuan, “LncRNA: a link between RNA and cancer,” Biochimica et Biophysica Acta, vol. 1839, no. 11, pp. 1097–1109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Zhu, H. Fu, Y. Wu, and X. Zheng, “Function of lncRNAs and approaches to lncRNA-protein interactions,” Science China Life Sciences, vol. 56, no. 10, pp. 876–885, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Zhou, C. Yin, Y. Dang, F. Ye, and G. Zhang, “Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer,” Scientific Reports, vol. 5, article 11516, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Liang, T. Lv, X. Shi et al., “Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer,” Medicine (Baltimore), vol. 95, no. 37, article e4608, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Jin, W. Shi, F. Wang et al., “Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer,” Oncotarget, vol. 7, no. 32, pp. 51763–51772, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Pang, J. Ge, Y. Shao et al., “Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance,” Tumour Biology, vol. 35, no. 6, pp. 5441–5447, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhao, Y. Liu, W. Zhang et al., “Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer,” Cell Cycle, vol. 14, no. 19, pp. 3112–3123, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ji, J. Tang, L. Deng et al., “LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway,” Oncotarget, vol. 6, no. 40, pp. 42813–42824, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Deng, X. F. Zhao, X. Q. Liang, R. Chen, Y. F. Pan, and J. Liang, “Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma,” Biomedicine & Pharmacotherapy, vol. 90, pp. 100–108, 2017. View at Publisher · View at Google Scholar
  20. Y. Wu, C. Tan, W. W. Weng et al., “Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma,” American Journal of Cancer Research, vol. 6, no. 2, pp. 285–299, 2016. View at Google Scholar
  21. B. Yue, D. Cai, C. Liu, C. Fang, and D. Yan, “Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer,” Molecular Therapy, vol. 24, no. 12, pp. 2064–2077, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Cai, Z. Q. Wang, S. H. Wang et al., “Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathway,” American Journal of Translational Research, vol. 8, no. 10, pp. 4068–4081, 2016. View at Google Scholar
  23. Q. Cai, Z. Wang, S. Wang et al., “Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138,” Open Biology, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  24. H. B. Hu, H. Y. Jie, and X. X. Zheng, “Three circulating LncRNA predict early progress of esophageal squamous cell carcinoma,” Cellular Physiology and Biochemistry, vol. 40, no. 1-2, pp. 117–125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Li, Y. Shao, X. Zhang et al., “Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer,” Tumour Biology, vol. 36, no. 3, pp. 2007–2012, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Gutschner and S. Diederichs, “The hallmarks of cancer: a long non-coding RNA point of view,” RNA Biology, vol. 9, no. 6, pp. 703–719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. N. B. Tsui, E. K. Ng, and Y. M. Lo, “Stability of endogenous and added RNA in blood specimens, serum, and plasma,” Clinical Chemistry, vol. 48, no. 10, pp. 1647–1653, 2002. View at Google Scholar
  28. M. Redova, J. Sana, and O. Slaby, “Circulating miRNAs as new blood-based biomarkers for solid cancers,” Future Oncology, vol. 9, no. 3, pp. 387–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Okamura, K. Takayama, M. Izumi, T. Harada, K. Furuyama, and Y. Nakanishi, “Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer,” Lung Cancer, vol. 80, no. 1, pp. 45–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. International Early Lung Cancer Action Program, C. I. Henschke, D. F. Yankelevitz et al., “Survival of patients with stage I lung cancer detected on CT screening,” The New England Journal of Medicine, vol. 355, no. 17, pp. 1763–1771, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. S. Tong, X. W. Wang, X. L. Zhou et al., “Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma,” Molecular Cancer, vol. 14, p. 3, 2015. View at Publisher · View at Google Scholar · View at Scopus